Blue Owl Capital Holdings »

Focus Impact Acquisition Cor shares owned by Blue Owl Capital Holdings

Quarter-by-quarter ownership of Focus Impact Acquisition Cor (FIACW) shares owned by Blue Owl Capital Holdings from 13F filings

Historical chart of Blue Owl Capital Holdings investment in Focus Impact Acquisition Cor

Tip: Access up to 7 years of quarterly data

All positions including Focus Impact Acquisition Cor held by Blue Owl Capital Holdings consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Focus Impact Acquisition Cor by Blue Owl Capital Holdings

Quarter filed Position value Share count Share price at filing
2024-09-30 $4.0k 100k 0.04

More positions owned by Blue Owl Capital Holdings

Nuveen Churchill Direct Lend Com Shs (NCDL)
Klaviyo Com Ser A (KVYO)
Tourmaline Bio (TRML)
Pliant Therapeutics (PLRX)
Cullinan Oncology (CGEM)
Owl Rock Capital Corporation (OBDC)
Larimar Therapeutics (LRMR)
Proshares Tr Ultrapro Qqq (TQQQ)
Engene Holdings (ENGN)
Evercommerce (EVCM)
Acelyrin (SLRN)
Conduent Incorporate (CNDT)
Repare Therapeutics Ord (RPTX)
Context Therapeutics (CNTX)
Ultragenyx Pharmaceutical (RARE)

View all positions for Blue Owl Capital Holdings

Top funds holding Focus Impact Acquisition Cor

Highbridge Capital Management
OZ Management
Periscope Capital
Polar Securities
Calamos Advisors
Cowen And Company
Taconic Capital Advisors
Davidson Kempner Capital Management
Wolverine Asset Management
D. E. Shaw & Co
Tenor Capital Management
683 Capital Management
CNH Partners
Marshall Wace
Citigroup

View all funds holding Focus Impact Acquisition Cor